AC Immune (NASDAQ:ACIU) stock shot up 20% Thursday after the company reported positive interim data from a Phase 2 study of its drug ACI-7104.056 in the treatment of early Parkinson’s disease ...

AC Immune’s stock price has jumped by more than 20% after all patients in a trial of its Parkinson’s disease vaccine-like immunotherapy responded to the target antigen. On Thursday (14 ...

The Postal Service called White “an icon of American television" and said she "shared her wit and warmth with viewers for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

For the latest updates on the release of the CLAT Admit card, students are advised to keep visiting the official website - consortiumofnlus.ac.in CLAT 2025 Admit Card Date and Time According to ...

For the latest updates on the release of the CLAT Admit card, students are advised to keep visiting the official website - consortiumofnlus.ac.in Step 4: The CLAT admit card 2025 will be displayed ...

AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early ...